123 related articles for article (PubMed ID: 23639578)
1. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
[TBL] [Abstract][Full Text] [Related]
2. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
[TBL] [Abstract][Full Text] [Related]
3. Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
Wang J; Zhang KS; Wang T; Liu Z; Wang RH; Zhang FQ; Yu L; Ran L; He JL; Wang YL; Wei LC; Shi M; Wang GQ; Wu CQ; Kang QJ; Yang J; Li S; Yang FY; Liu BG; Liu JY; Shi F; Su J; Yuan W; Drokow EK
BMC Cancer; 2019 Dec; 19(1):1219. PubMed ID: 31842811
[TBL] [Abstract][Full Text] [Related]
4. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
[TBL] [Abstract][Full Text] [Related]
5. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
[TBL] [Abstract][Full Text] [Related]
6. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
7. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
[TBL] [Abstract][Full Text] [Related]
8. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
9. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
[TBL] [Abstract][Full Text] [Related]
10. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
[TBL] [Abstract][Full Text] [Related]
11. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
12. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
13. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
15. Optimized dose distribution of Gammamed plus vaginal cylinders.
Supe SS; Bijina TK; Varatharaj C; Shwetha B; Arunkumar T; Sathiyan S; Ganesh KM; Ravikumar M
Med Dosim; 2009; 34(1):20-5. PubMed ID: 19181251
[TBL] [Abstract][Full Text] [Related]
16. Comments on - vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Krishnamurthy S; Pathy S; Ahmed I; Chander S
Radiother Oncol; 2014 Dec; 113(3):426. PubMed ID: 24931293
[No Abstract] [Full Text] [Related]
17. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
[TBL] [Abstract][Full Text] [Related]
18. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
19. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
[TBL] [Abstract][Full Text] [Related]
20. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
